Recent Updates
Recently added Catalysts
QDEL Positive Sentiment

QuidelOrtho to Report Third Quarter 2025 Financial Results QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, announced today that it will report ...

Key Takeaway: QuidelOrtho Corporation will report its financial results for Q3 2025 on November 5, 2025, after market close. A conference call to discuss these results is scheduled for the same day at 2:00 p.m. PT. Interested parties can access the call via the company's website or by phone.
Price reaction · baseline $29.83 (2025-10-21 close) · hit after-hours · 1 other QDEL headline(s) in the window, move may be shared
day 0 close
-0.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • QuidelOrtho is a leader in in vitro diagnostics.
  • The upcoming conference call will provide insights into financial performance.
  • The company is dedicated to advancing diagnostics for better patient outcomes.

Full Press Release Details

SAN DIEGO , Oct. 22, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL ) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, announced today that it will report its financial results for the third quarter 2025 ended September 28, 2025, after the market closes on Wednesday, November 5, 2025.
Following the release of financial results, QuidelOrtho will hold a conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results. Interested parties can access the call from the "Events & Presentations" section of the "Investor Relations" page of the Company's website at https://ir.quidelortho.com . Presentation materials will also be posted to the "Events & Presentations" section of the "Investor Relations" page of the Company's website at the time of the call. Those unable to access the webcast may join the call via phone by dialing 833-470-1428 (domestic) or +1 929-526-1599 (international) and entering Conference ID number 415850.
A replay of the conference call will be available shortly after the event on the "Investor Relations" page of the Company's website under the "Events & Presentations" section.
QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.
About QuidelOrtho Corporation
With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL ) is a leading global provider of diagnostic solutions, delivering fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.
Investor Contact: Juliet Cunningham Vice President, Investor Relations [email protected]
Media Contact: D. Nikki Wheeler Senior Director, Corporate Communications [email protected]

Frequently Asked Questions

When will QuidelOrtho report its Q3 2025 financial results?

QuidelOrtho will report its Q3 2025 financial results on November 5, 2025.

What time is the conference call for Q3 2025 results?

The conference call will begin at 2:00 p.m. PT on November 5, 2025.

How can I access the conference call?

The call can be accessed via the company's website or by phone.

Where can I find the presentation materials?

Presentation materials will be posted on the Investor Relations page during the call.

Last updated: Oct 22, 2025